The Hill
Monday, October 13, 2008
SEARCH
Home
HillTube
Mobile
White Papers Portal
BLOGS
Pundits Blog
Congress Blog
Blog Briefing Room
NEWS
Leading The News
Business & Lobbying
K Street Insiders
John Breaux
John Engler
Vin Weber
Dave Wenhold
The Executive
Campaign 2008
Endorsements '08
COLUMNISTS
Dick Morris
A.B. Stoddard
Brent Budowsky
Ben Goddard
David Hill
David Keene
Josh Marshall
Mark Mellman
Jim Mills
Markos Moulitsas (Kos)
Byron York
COMMENT
Editorial
Letters
Op-eds
Weyant's World
CAPITAL LIVING
Today's Stories
50 Most Beautiful 2008
Other Features
In The Know
Bookshelf
Food & Drink
Onward and Upward
Hillscape
RESOURCES
Classifieds
Subscribe
Order Reprints
Last Six Issues
Useful Links
RSS


Home arrow White Papers arrow American Clinical Laboratory Association (ACLA)
THE HILL WHITE PAPERS
American Clinical Laboratory Association (ACLA)
About Us
The American Clinical Laboratory Association (ACLA) is the clinical laboratory industry's leading advocate providing effective communication with Congress, regulatory bodies, other health care organizations and the public.  A not-for-profit association, ACLA represents the nation's leading national and regional clinical laboratories on key issues of common concern, including federal and state government reimbursement and regulatory policies. Its primary purpose is to: advocate laws and regulations that recognize the essential role that laboratory services play in delivering cost-effective health care; encourage the highest standards of quality, service and ethical conduct among its members; and promote public awareness about the value of laboratory services in preventing illness, diagnosing disease, and monitoring medical treatment.

Position Papers: Click to download

Healthcare

Comment on Genetic Testing Before Senate Special Committee on Aging Genetic Testing Roundtable
Summary: On June 12, 2008 the Senate Special Committee Aging held a Genetic Test Roundtable Discussion.  Dr. Elaine Lyon, Medical Director of Molecular Genetics at ARUP Laboratories represented ACLA on a panel that included representatives from FDA, CMS, the National Human Genome Research Institute, the Johns Hopkins Genetics and Public Policy Center and web based company 23andMe. The roundtable was organized by Senator Gordon Smith (R-OR), as a follow-up to a 2006 Congressional Hearing on Nutrigenetic Testing held by this committee.  In his opening remarks, Senator Smith referred back to the 2006 Hearing which revealed questionable practices related to some direct to consumer genetic tests. He described the purpose of this briefing as an opportunity to revisit the safety and effectiveness of these tests and to determine whether additional protection is needed for consumers.

Home | Privacy Policy | Terms And Conditions
The Hill
1625 K Street, NW Suite 900
Washington, DC 20006
202-628-8500 tel | 202-628-8503 fax

The contents of this site are © 2008 Capitol Hill Publishing Corp., a subsidiary of News Communications, Inc.